Giedre Krenciute

25PUBLICATIONS
123CO-AUTHORS
Molecular targetsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 30, 2026
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs.

Jorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio

|Feb 27, 2026
Antigen Specificity and Cell Engineering Determine CAR T Cell Efficacy in Group 3 Medulloblastoma.

Giedre Krenciute, Meghan Ward, Justine Fouliard

|Feb 04, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor.

Chiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin

|Feb 02, 2026
LRRC15-CAR T Cells for the Treatment of Osteosarcoma.

Carla O'Reilly, Shraddha Tuladhar, Phuong Nguyen

|Jul 23, 2025
Early methionine availability attenuates T cell exhaustion.

Piyush Sharma, Ao Guo, Suresh Poudel

|Jun 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response.

Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan

Pageof 5